Sarwish Rafiq

9PUBLICATIONS
93CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 22, 2026
Modulating the VIP-VIPR pathway reprograms CAR T cells for superior antitumor efficacy in preclinical cancer models.

|Apr 14, 2025
Combination radiation and αPD-L1 enhance tumor control by stimulating CD8+ PD-1+ TCF-1+ T cells in the tumor-draining lymph node.

Yang Shen, Erin Connolly, Meili Aiello

|Mar 18, 2024
Radiation and anti-PD-L1 synergize by stimulating a stem-like T cell population in the tumor-draining lymph node.

Yang Shen, Erin Connolly, Meili Aiello

|Jan 21, 2024
Engineering Improved CAR T Cell Products with A Multi-Cytokine Particle Platform for Hematologic and Solid Tumors.

Heather K Lin, Biaggio Uricoli, Ruby Freeman

|Nov 22, 2023
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity.

Hao Fan, Siyuan Xia, Junhong Xiang

|Jul 19, 2023
Siglec-15 Promotes Evasion of Adaptive Immunity in B-cell Acute Lymphoblastic Leukemia.

Claire E Pillsbury, Jodi Dougan, Jennifer L Rabe

Pageof 2

Frequent Collaborators

3 joint publications

Chrystal M Paulos

3 joint publications

Christopher C Porter

2 joint publications

Alexandre Orthwein

2 joint publications

Gregory B Lesinski